Peptide record

TPDB11162

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
29 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11162
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 29-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GFMDTAKNAAKNVAVTLLDNLKCKITKAC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C133H229N37O40S3
REQHPSWY
AK
3082.69
9.65
5
2
13
+3
0.94
0.121
91.03
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.04
8
Residue Composition
number
5
A
0
R
3
N
2
D
2
C
0
E
0
Q
1
G
0
H
1
I
3
L
5
K
1
M
1
F
0
P
0
S
3
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 5 R: 0 N: 3 D: 2 C: 2 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 3 K: 5 M: 1 F: 1 P: 0 S: 0 T: 3 W: 0 Y: 0 V: 2
Chemical Descriptors
29 reviewed residue count
C133H229N37O40S3 sequence-only estimate (linear, free termini)
3082.69 sequence-only estimate (linear, free termini)
9.65 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.94 sequence-only estimate (linear, free termini)
0.121 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

% Hemolysis
Hemolysis
3.5 %
[Ref.17272268] RCH=15.4 ± 3.5% against rabbit red blood cells at 50 µg/ml. RCH, red cell hemolysis.

Target

rabbit red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Mol Cell Proteomics. 2007 May 6(5):882-894.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

15% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
15% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 3 Activity

Activity

(7.7±2.6)% degranulation
Toxicity
50 µg/mL
Cytotoxic
(7.7±2.6)% degranulation | 50 | µg/mL | target cell: Human mast cells

Target

Human mast cells

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 4 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.17272268] RCH=15.4 ± 3.5% against rabbit red blood cells at 50 µg/ml. RCH, red cell hemolysis.

Target

erythrocytes

Source & Reference

NA
DRAMP
Mol Cell Proteomics. 2007 May 6(5):882-894.
Evidence 5 Hemolysis

Activity

3.5 %
% Hemolysis
[Ref.17272268] RCH=15.4 ± 3.5% against rabbit red blood cells at 50 µg/ml. RCH, red cell hemolysis.
Hemolysis

Target

rabbit red blood cells

Source & Reference

HemoPI PD_Hemolysis
Mol Cell Proteomics. 2007 May 6(5):882-894.
DRAMP4
PD_Hemolysis